Tag: B-cell lymphoma

According to an NIH study, immunotherapy significantly improves the survival rate for persons with lymphomatoid granulomatosis.

According to the findings of a clinical experiment done by scientists at the National Institutes of Health (NIH), individuals with low-grade lymphomatoid granulomatosis who receive immunotherapy known as interferon alfa-2b can live for decades after being diagnosed. Epstein-Barr virus infection…

Back to top

Registration Form


This will close in 0 seconds

This will close in 0 seconds

WhatsApp Join Telegram